Tirzepatide, a once-weekly GIP/GLP-1 receptor agonist, is a medicine used for weight reduction in adults with obesity. A new analysis of the SURMOUNT clinical trials reveals that the medicine, ...
Woman's World on MSN
176 lbs-gone! Why one woman's gentle weight-loss tips really work
We have some refreshing news: Going gently may be the new way to get healthy. Forget harsh, exhausting weight-loss plans. Research in the Journal of Happiness and Health shows that replacing a ...
In the context of the global obesity epidemic, the FDA approved several glucagon-like peptide-1 (GLP-1) receptor agonists (GPL-1RAs), such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) as ...
Small lifestyle changes can help you lose weight without needing a complete diet overhaul, according to NHS advice ...
A new once-a-month injection helped people with obesity shed up to 16% of their body weight, offering fresh hope for effective, long-acting treatments. Can this breakthrough change the landscape for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results